DIAGNOS (OTCMKTS:DGNOF) Stock Price Up 33.4% – Should You Buy?

DIAGNOS Inc. (OTCMKTS:DGNOF)’s share price rose 33.4% during trading on Tuesday . The stock traded as high as $0.23 and last traded at $0.2001. Approximately 64,990 shares changed hands during mid-day trading, a decline of 46% from the average daily volume of 120,684 shares. The stock had previously closed at $0.15.

DIAGNOS Stock Performance

The company has a debt-to-equity ratio of 0.33, a current ratio of 1.49 and a quick ratio of 1.49. The business has a 50 day moving average price of $0.16 and a 200 day moving average price of $0.19. The stock has a market capitalization of $24.22 million, a PE ratio of -5.00 and a beta of -0.09.

DIAGNOS (OTCMKTS:DGNOF) last posted its quarterly earnings results on Thursday, June 11th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The company had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.05 million.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.